##gff-version 3
##sequence-region P23945 1 695
P23945	UniProtKB	Signal peptide	1	17	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
P23945	UniProtKB	Chain	18	695	.	.	.	ID=PRO_0000012771;Note=Follicle-stimulating hormone receptor	
P23945	UniProtKB	Topological domain	18	366	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P23945	UniProtKB	Transmembrane	367	387	.	.	.	Note=Helical%3B Name%3D1;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P23945	UniProtKB	Topological domain	388	398	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P23945	UniProtKB	Transmembrane	399	421	.	.	.	Note=Helical%3B Name%3D2;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P23945	UniProtKB	Topological domain	422	443	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P23945	UniProtKB	Transmembrane	444	465	.	.	.	Note=Helical%3B Name%3D3;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P23945	UniProtKB	Topological domain	466	485	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P23945	UniProtKB	Transmembrane	486	508	.	.	.	Note=Helical%3B Name%3D4;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P23945	UniProtKB	Topological domain	509	528	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P23945	UniProtKB	Transmembrane	529	550	.	.	.	Note=Helical%3B Name%3D5;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P23945	UniProtKB	Topological domain	551	573	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P23945	UniProtKB	Transmembrane	574	597	.	.	.	Note=Helical%3B Name%3D6;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P23945	UniProtKB	Topological domain	598	608	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P23945	UniProtKB	Transmembrane	609	630	.	.	.	Note=Helical%3B Name%3D7;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P23945	UniProtKB	Topological domain	631	695	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P23945	UniProtKB	Domain	18	46	.	.	.	Note=LRRNT	
P23945	UniProtKB	Repeat	49	72	.	.	.	Note=LRR 1	
P23945	UniProtKB	Repeat	73	97	.	.	.	Note=LRR 2	
P23945	UniProtKB	Repeat	98	118	.	.	.	Note=LRR 3	
P23945	UniProtKB	Repeat	119	143	.	.	.	Note=LRR 4	
P23945	UniProtKB	Repeat	144	169	.	.	.	Note=LRR 5	
P23945	UniProtKB	Repeat	170	192	.	.	.	Note=LRR 6	
P23945	UniProtKB	Repeat	193	216	.	.	.	Note=LRR 7	
P23945	UniProtKB	Repeat	217	240	.	.	.	Note=LRR 8	
P23945	UniProtKB	Repeat	241	259	.	.	.	Note=LRR 9	
P23945	UniProtKB	Modified residue	335	335	.	.	.	Note=Sulfotyrosine;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:11847099;Dbxref=PMID:11847099	
P23945	UniProtKB	Glycosylation	191	191	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000244,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PDB:4MQW,ECO:0000269|PubMed:15662415,ECO:0000269|PubMed:24692546;Dbxref=PMID:15662415,PMID:24692546	
P23945	UniProtKB	Glycosylation	199	199	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P23945	UniProtKB	Glycosylation	293	293	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P23945	UniProtKB	Glycosylation	318	318	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P23945	UniProtKB	Disulfide bond	18	25	.	.	.	Ontology_term=ECO:0000244,ECO:0000255,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PDB:4MQW,ECO:0000255|PROSITE-ProRule:PRU00521,ECO:0000269|PubMed:15662415,ECO:0000269|PubMed:24692546;Dbxref=PMID:15662415,PMID:24692546	
P23945	UniProtKB	Disulfide bond	23	32	.	.	.	Ontology_term=ECO:0000244,ECO:0000255,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PDB:4MQW,ECO:0000255|PROSITE-ProRule:PRU00521,ECO:0000269|PubMed:15662415,ECO:0000269|PubMed:24692546;Dbxref=PMID:15662415,PMID:24692546	
P23945	UniProtKB	Disulfide bond	275	346	.	.	.	Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:4MQW,ECO:0000269|PubMed:24692546;Dbxref=PMID:24692546	
P23945	UniProtKB	Disulfide bond	276	356	.	.	.	Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:4MQW,ECO:0000269|PubMed:24692546;Dbxref=PMID:24692546	
P23945	UniProtKB	Disulfide bond	276	292	.	.	.	Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:4MQW,ECO:0000269|PubMed:24692546;Dbxref=PMID:24692546	
P23945	UniProtKB	Disulfide bond	292	338	.	.	.	Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:4MQW,ECO:0000269|PubMed:24692546;Dbxref=PMID:24692546	
P23945	UniProtKB	Disulfide bond	442	517	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00521	
P23945	UniProtKB	Alternative sequence	149	174	.	.	.	ID=VSP_043181;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
P23945	UniProtKB	Alternative sequence	223	223	.	.	.	ID=VSP_053411;Note=In isoform 4. L->LNRRTRTPTEPNVLLAKYPSGQGVLEEPESLSSSI;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P23945	UniProtKB	Alternative sequence	224	285	.	.	.	ID=VSP_001953;Note=In isoform Short. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:1359889;Dbxref=PMID:1359889	
P23945	UniProtKB	Natural variant	128	128	.	.	.	ID=VAR_039279;Note=In OHSS%3B displays increase in affinity and sensitivity toward hCG and does not show any constitutive activity nor promiscuous activation by TSH. S->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17721928;Dbxref=PMID:17721928	
P23945	UniProtKB	Natural variant	160	160	.	.	.	ID=VAR_018045;Note=In ODG1%3B impairs cell surface expression. I->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9769327;Dbxref=PMID:9769327	
P23945	UniProtKB	Natural variant	189	189	.	.	.	ID=VAR_018046;Note=In ODG1%3B very frequent in the Finnish population. A->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7553856,ECO:0000269|PubMed:9851774;Dbxref=PMID:7553856,PMID:9851774	
P23945	UniProtKB	Natural variant	224	224	.	.	.	ID=VAR_039280;Note=In ODG1%3B FSH binding is barely detectable%3B impaired targeting to the cell membrane%3B adenylate cyclase stimulation by FSH is 4 +-2%25 residual activity. D->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10551778;Dbxref=PMID:10551778	
P23945	UniProtKB	Natural variant	307	307	.	.	.	ID=VAR_013903;Note=A->T;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10391209,ECO:0000269|PubMed:12059813,ECO:0000269|PubMed:1301382,ECO:0000269|PubMed:1322283,ECO:0000269|PubMed:1359889,ECO:0000269|PubMed:14702039,ECO:0000269|PubMed:15489334,ECO:0000269|PubMed:7916967,ECO:0000269|Ref.5;Dbxref=dbSNP:rs6165,PMID:10391209,PMID:12059813,PMID:1301382,PMID:1322283,PMID:1359889,PMID:14702039,PMID:15489334,PMID:7916967	
P23945	UniProtKB	Natural variant	348	348	.	.	.	ID=VAR_039281;Note=In ODG1. P->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12571157;Dbxref=PMID:12571157	
P23945	UniProtKB	Natural variant	419	419	.	.	.	ID=VAR_018047;Note=In ODG1. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11889179;Dbxref=PMID:11889179	
P23945	UniProtKB	Natural variant	449	449	.	.	.	ID=VAR_039282;Note=In OHSS%3B increase of receptor sensitivity to both hCG and TSH together with an increase in basal activity. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15080154;Dbxref=PMID:15080154	
P23945	UniProtKB	Natural variant	449	449	.	.	.	ID=VAR_017244;Note=In OHSS. T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12930927;Dbxref=dbSNP:rs28928870,PMID:12930927	
P23945	UniProtKB	Natural variant	512	512	.	.	.	ID=VAR_074535;Note=In OHSS%3B inhibits activation of PI3K/AKT signaling pathway%3B reduces cAMP production%3B no effect on ERK1/2 signaling pathway activation. M->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24058690;Dbxref=PMID:24058690	
P23945	UniProtKB	Natural variant	514	514	.	.	.	ID=VAR_074536;Note=In OHSS%3B increases cell surface expression%3B no effect on hormone binding%3B increases signaling activity. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25581598;Dbxref=PMID:25581598	
P23945	UniProtKB	Natural variant	519	519	.	.	.	ID=VAR_039283;Note=In ODG1%3B totally impairs adenylate cyclase stimulation in vitro%3B alters the cell surface targeting of the receptor which remains trapped intracellularly. P->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12915623;Dbxref=PMID:12915623	
P23945	UniProtKB	Natural variant	524	524	.	.	.	ID=VAR_013904;Note=S->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10391209;Dbxref=dbSNP:rs6167,PMID:10391209	
P23945	UniProtKB	Natural variant	545	545	.	.	.	ID=VAR_039284;Note=In OHSS%3B displays promiscuous activation by both hCG and TSH together with detectable constitutive activity. I->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16278261;Dbxref=PMID:16278261	
P23945	UniProtKB	Natural variant	567	567	.	.	.	ID=VAR_039285;Note=Activating mutation resulting in 1.5-fold increase in basal cAMP production compared to the wild-type receptor. D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8636335;Dbxref=PMID:8636335	
P23945	UniProtKB	Natural variant	567	567	.	.	.	ID=VAR_017245;Note=In OHSS. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12930928;Dbxref=dbSNP:rs28928871,PMID:12930928	
P23945	UniProtKB	Natural variant	573	573	.	.	.	ID=VAR_018048;Note=In ODG1%3B alters signal transduction of the receptor%3B adenylate cyclase stimulation by FSH is 24 +-4%25 residual activity. R->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10551778,ECO:0000269|PubMed:9769327;Dbxref=PMID:10551778,PMID:9769327	
P23945	UniProtKB	Natural variant	575	575	.	.	.	ID=VAR_074537;Note=In OHSS%3B decreases cell surface expression%3B no effect on hormone binding%3B increases levels of internalized hormone receptor complex%3B cAMP levels are similar to basal levels even at high doses of FSH stimulation indicating reduced signaling. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25581598;Dbxref=PMID:25581598	
P23945	UniProtKB	Natural variant	591	591	.	.	.	ID=VAR_018049;Note=In ovarian sex cord tumor%3B loss of function. F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9100567;Dbxref=PMID:9100567	
P23945	UniProtKB	Natural variant	601	601	.	.	.	ID=VAR_039286;Note=In ODG1%3B binds FSH with a similar affinity than the wild-type receptor%3B adenylate cyclase stimulation by FSH is 12 +-3%25 residual activity. L->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10551778;Dbxref=PMID:10551778	
P23945	UniProtKB	Natural variant	680	680	.	.	.	ID=VAR_013905;Note=Associated with longer menstrual cycles. N->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10391209,ECO:0000269|PubMed:12059813,ECO:0000269|PubMed:15489334,ECO:0000269|PubMed:15815621,ECO:0000269|PubMed:1709010,ECO:0000269|PubMed:7916967,ECO:0000269|Ref.8;Dbxref=dbSNP:rs6166,PMID:10391209,PMID:12059813,PMID:15489334,PMID:15815621,PMID:1709010,PMID:7916967	
P23945	UniProtKB	Mutagenesis	330	330	.	.	.	Note=No change in intracellular cAMP accumulation. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11847099;Dbxref=PMID:11847099	
P23945	UniProtKB	Mutagenesis	335	335	.	.	.	Note=Reduces intracellular cAMP accumulation. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11847099;Dbxref=PMID:11847099	
P23945	UniProtKB	Sequence conflict	13	13	.	.	.	Note=S->R;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P23945	UniProtKB	Sequence conflict	112	112	.	.	.	Note=N->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P23945	UniProtKB	Sequence conflict	197	198	.	.	.	Note=EL->AV;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P23945	UniProtKB	Sequence conflict	295	295	.	.	.	Note=S->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P23945	UniProtKB	Beta strand	21	26	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4AY9	
P23945	UniProtKB	Beta strand	29	34	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4AY9	
P23945	UniProtKB	Beta strand	49	55	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4AY9	
P23945	UniProtKB	Beta strand	59	61	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4AY9	
P23945	UniProtKB	Turn	63	68	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1XWD	
P23945	UniProtKB	Beta strand	74	78	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4AY9	
P23945	UniProtKB	Turn	88	90	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4MQW	
P23945	UniProtKB	Beta strand	99	105	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4AY9	
P23945	UniProtKB	Beta strand	115	117	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1XWD	
P23945	UniProtKB	Beta strand	124	130	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4AY9	
P23945	UniProtKB	Beta strand	143	145	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4AY9	
P23945	UniProtKB	Beta strand	147	153	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4AY9	
P23945	UniProtKB	Beta strand	168	171	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4AY9	
P23945	UniProtKB	Beta strand	173	176	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4AY9	
P23945	UniProtKB	Turn	187	192	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4MQW	
P23945	UniProtKB	Beta strand	193	199	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4AY9	
P23945	UniProtKB	Turn	211	216	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4AY9	
P23945	UniProtKB	Beta strand	221	224	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4AY9	
P23945	UniProtKB	Beta strand	235	237	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4AY9	
P23945	UniProtKB	Beta strand	243	245	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4AY9	
P23945	UniProtKB	Turn	258	260	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4AY9	
P23945	UniProtKB	Beta strand	266	268	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4AY9	
P23945	UniProtKB	Helix	272	280	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4AY9	
P23945	UniProtKB	Beta strand	345	348	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4AY9	
P23945	UniProtKB	Beta strand	351	353	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4MQW	
